The DOI matches its Crossref record; 241 of the 242 references it cites were found in a registry or an index; none of the 155 sources its claims cite is checked for support yet.
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Open accessAbstract
This paper discusses the mechanisms of S. aureus drug resistance including: (1) introduction. (2) resistance to beta-lactam antibiotics, with particular emphasis on the mec genes found in the Staphylococcaceae family, the structure and occurrence of SCCmec cassettes, as well as differences in the presence of some virulence genes and its expression in major epidemiological types and clones of HA-MRSA, CA-MRSA, and LA-MRSA strains. Other mechanisms of resistance to beta-lactam antibiotics will also be discussed, such as mutations in the gdpP gene, BORSA or MODSA phenotypes, as well as resistance to ceftobiprole and ceftaroline. (3) Resistance to glycopeptides (VRSA, VISA, hVISA strains, vancomycin tolerance). (4) Resistance to oxazolidinones (mutational and enzymatic resistance to linezolid). (5) Resistance to MLS-B (macrolides, lincosamides, ketolides, and streptogramin B). (6) Aminoglycosides and spectinomicin, including resistance genes, their regulation and localization (plasmids, transposons, class I integrons, SCCmec), and types and spectrum of enzymes that inactivate aminoglycosides. (7). Fluoroquinolones (8) Tetracyclines, including the mechanisms of active protection of the drug target site and active efflux of the drug from the bacterial cell. (9) Mupirocin. (10) Fusidic acid. (11) Daptomycin. (12) Resistance to other antibiotics and chemioterapeutics (e.g., streptogramins A, quinupristin/dalfopristin, chloramphenicol, rifampicin, fosfomycin, trimethoprim) (13) Molecular epidemiology of MRSA.
Overview
CoChat Summary
TL;DR
This review summarizes molecular mechanisms of drug resistance in *Staphylococcus aureus*, covering beta-lactams, glycopeptides, oxazolidinones, MLS-B, aminoglycosides, fluoroquinolones, tetracyclines, mupirocin, fusidic acid, daptomycin, and other agents. It emphasizes SCC*mec*/*mec*-mediated methicillin resistance, VanA-mediated glycopeptide resistance, and mobile genetic elements as drivers of multidrug resistance.
Key findings
- Methicillin resistance is chiefly mediated by PBP2A encoded by *mec* genes within SCC*mec* cassettes; 14 major SCC*mec* types have been described, ranging from 21 to 82 thousand nucleotides, with *mecA*, *mecC*, and other *mec* variants distributed across staphylococci.
- Beta-lactam resistance also involves beta-lactamases (*blaZ*) and rare PBP mutations; a *mecA*-negative CRB strain had ceftobiprole MIC = 128 mg/L, ceftriaxone MIC = 256 mg/L, cefazolin MIC > 256 mg/L, nafcillin MIC = 128 mg/L, ampicillin MIC = 256 mg/L, and cefoxitin MIC = 8 mg/L.
- Glycopeptide resistance via the VanA operon in Tn*1546* confers vancomycin MIC 64–1024 mg/L and teicoplanin MIC 16–512 mg/L; only about a dozen VRSA strains with VanA have been described. In 187 MRSA strains from 41 Spanish hospitals, vancomycin tolerance was 9.6% and teicoplanin tolerance 21.9%.
- Aminoglycoside resistance commonly involves AAC(6′)-Ie/APH(2″)-Ia, the only enzyme known in *S. aureus* to determine gentamicin resistance; gentamicin MICs ranged from 8 mg/L to >1024 mg/L (MIC50 128 mg/L, MIC90 512 mg/L), and tobramycin MICs ranged from 8 to 256 mg/L (MIC50 32 mg/L, MIC90 64 mg/L).
Methods
- Design: narrative review of published literature on molecular resistance mechanisms in *S. aureus*; no systematic review protocol or primary experimental study is described.
- Data or sample: Not stated in the paper; the text cites clinical isolates, strains, plasmids, transposons, integrons, and SCC*mec* elements from prior studies.
- Main analysis: descriptive synthesis organized by antibiotic class and molecular epidemiology, including referenced tables and figures on SCC*mec* types, *mec*/*ccr* complexes, and MRSA clones.
Limitations
- The paper states no limitations section.
- Evident: as a narrative review, it lacks systematic search, inclusion criteria, and formal risk-of-bias assessment.
- Evident: it presents no new primary data and relies on previously published studies; several tables and figures are referenced but not included in the provided text, limiting verification of clone and SCC*mec* details.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 6 Not valid · 95 Not checked · 5 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“In 2006, the first class I integrons, previously described in Gram-negative bacteria, were detected in staphylococci, initially found in coagulase-negative staphylococci and later in S. aureus.”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 1. Introduction
What the sources say
- Not checked yetcites [8] Shi, 2006, Unnoticed spread of class 1 integrons in gram-positive clinical strains isolated in Guangzhou, China, Microbiol. Immunol. source
- Not checked yetcites [9] Xu, 2008, First confirmation of integron-bearing methicillin-resistant Staphylococcus aureus, Curr. Microbiol. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The cassette genes functioning in these integrons that determine resistance to streptomycin (aadA2, aadA5), chloramphenicol (cmlA1) and trimethoprim (dfrA12, dfr17) have also been described [8,9].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 1. Introduction
What the sources say
- Not checked yetcites [8] Shi, 2006, Unnoticed spread of class 1 integrons in gram-positive clinical strains isolated in Guangzhou, China, Microbiol. Immunol. source
- Not checked yetcites [9] Xu, 2008, First confirmation of integron-bearing methicillin-resistant Staphylococcus aureus, Curr. Microbiol. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“However, the mere presence of a pathogenicity factor gene does not always equate to its expression, which is subject to one or more regulatory systems present in the bacterial cell, such as the Agr/Sar system [10]”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 1. Introduction
What the sources say
- Not checked yetcites [10] Butrico, C.E., and Cassat, J.E. (2020). Quorum sensing and toxin production in Staphylococcus aureus osteomyelitis: Pathogenesis and paradox. Toxins, 12. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The mecA gene has been detected in S. aureus, S. pseudintermedius, Mammallicoccus fleuretti (former name Staphylococcus fleuretti), Mammallicoccus vitulinus (former name Staphylococcus vitulinus), Mammallicoccus sciuri (former name Staphylococcus sciuri) and in many other species of the genus Staphylococcus currently comprising 64 species [21].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 2. Resistance to Beta-Lactam Antibiotics > 2.2. PBP2A Synthesis (Methicillin-Resistance)
What the sources say
- Not checked yetcites [21] (2022, February 03). Taxonomy Browser (Staphylococcus), Available online: https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Single strains of the so-called BORSA (borderline oxacillin-resistant S. aureus) have been described, in which the synthesized beta-lactamase had an extended spectrum and conditioned an oxacillin MIC of 4–8 mg/L [15].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 2. Resistance to Beta-Lactam Antibiotics > 2.1. Synthesis of Beta-Lactamases
What the sources say
- Not checked yetcites [15] Balslev, 2005, An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit, Microb. Drug Resist. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
57 more claims
Create a free account to see all 106 claims and to verify the 155 references still open.
- It may state two separate claims as one. 35
- Probably not a substantial claim. 15
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In MRSA, PBP2a maintains transpeptidase activity even under β-lactam exposure, enabling cross-linking of pentaglycan bridges between peptidoglycan chains [9,198].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
In the citing paper
“Resistance extends to all β-lactams except ceftobiprole and ceftaroline, which retain activity against PBP2a [9,203].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
In the citing paper
“Constitutive expression occurs in strains with ΔmecR1-mecA deletions [9,202].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
In the citing paper
“The mecA gene, located on the staphylococcal chromosomal cassette mec (SCCmec), produces PBP2a (also termed PBP2′), a 668-amino-acid protein that replaces the transpeptidase function of native PBPs inhibited by β-lactams [9,195,197].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 12. Other Antibiotics > 12.3. Resistance to Chloramphenicol
“A mutation in the rpoB gene (A1345G; substitution in RpoB protein D449N) was also described, conditioning the resistance of S. aureus strain to chloramphenicol (MIC-128 mg/L) and intermediate to oxazolidinones [94].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 4. Resistance to Oxazolidinones
“A mutation in the rpoB gene (A1345G; substitution in the RpoB protein D449N) was also described, which determines the resistance of S. aureus strain to linezolid (MIC = 8 mg/L) and tedizolid (MIC = 4 mg/L), chloramphenicol (MIC-128 mg/L), medium sensitivity to quinupristin/dalphopristin (MIC-2 mg/L) [94].”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 5. Resistance to Macrolides, Lincosamides, Ketolides and Streptogramins B
“VgbA, VgbB, inactivating streptogramin B lyases”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 12. Other Antibiotics > 12.1. Resistance to Streptogramins A and Quinupristin-Dalfopristin
“Resistance to streptogramins A in S. aureus may result from the production of enzymes that inactivate streptogramins A such as Vat acetyltransferases encoded by the plasmid genes vatA [179], vatB located in the Tn5406 transposon [180,181], vatC [130], vatD, vatE [130] or Vgb lyases encoded by the vgb(A) and vgb(B) genes [131].”
Citations
Cites
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Oliveira, D. C., & Lencastre, H. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2155-2161.2002 · Cited by 1,343
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
Kondo, Y., Ito, T., Ma, X. X., Watanabe, S., Kreiswirth, B. N., Etienne, J., & Hiramatsu, K. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00165-06 · Cited by 965
Ito, T., Katayama, Y., Asada, K., Mori, N., Tsutsumimoto, K., Tiensasitorn, C., & Hiramatsu, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1323-1336.2001 · Cited by 963
García-Álvarez, L., Holden, M. T., Lindsay, H., Webb, C. R., Brown, D. F., Curran, M. D., Walpole, E., Brooks, K., Pickard, D. J., Teale, C., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70126-8 · Cited by 939
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community
Okuma, K., Iwakawa, K., Turnidge, J. D., Grubb, W. B., Bell, J. M., O'Brien, F. G., Coombs, G. W., Pearman, J. W., Tenover, F. C., Kapi, M., et al. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4289-4294.2002 · Cited by 888
(2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00579-09 · Cited by 804
Ito, T., Ma, X. X., Takeuchi, F., Okuma, K., Yuzawa, H., & Hiramatsu, K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2637-2651.2004 · Cited by 675
Ma, X. X., Ito, T., Tiensasitorn, C., Jamklang, M., Chongtrakool, P., Boyle-Vavra, S., Daum, R. S., & Hiramatsu, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1147-1152.2002 · Cited by 587
Baba, T., Bae, T., Schneewind, O., Takeuchi, F., & Hiramatsu, K. (2008) · Journal of Bacteriology · doi:10.1128/jb.01000-07 · Cited by 563
Update to the Multiplex PCR Strategy for Assignment of mec Element Types in Staphylococcus aureus
Milheiriço, C., Oliveira, D. C., & de Lencastre, H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00275-07 · Cited by 490
Vancomycin resistance in Staphylococcus aureus
Appelbaum, P. C., & Bozdogan, B. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.03.004 · Cited by 485
Horinouchi, S., & Weisblum, B. (1982) · Journal of Bacteriology · doi:10.1128/jb.150.2.804-814.1982 · Cited by 471
Ito, T., Katayama, Y., & Hiramatsu, K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1449 · Cited by 450
Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC
Ito, T., Okuma, K., Ma, X. X., Yuzawa, H., & Hiramatsu, K. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00003-7 · Cited by 424
(2006) · ASM Press eBooks · doi:10.1128/9781555816513 · Cited by 417
Tristan, A., Bes, M., Meugnier, H., Lina, G., Bozdogan, B., Courvalin, P., Reverdy, M.-E., Enright, M. C., Vandenesch, F., & Etienne, J. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1304.061316 · Cited by 410
Chongtrakool, P., Ito, T., Ma, X. X., Kondo, Y., Trakulsomboon, S., Tiensasitorn, C., Jamklang, M., Chavalit, T., Song, J.-H., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1001-1012.2006 · Cited by 378
MRSA Transmission between Cows and Humans
Juhász-Kaszanyitzky, É., Jánosi, S., Somogyi, P., Dán, Á., van Bloois, L. V., van Duijkeren, E., & Wagenaar, J. A. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1304.060833 · Cited by 333
Diep, B. A., Carleton, H. A., Chang, R. F., Sensabaugh, G. F., & Perdreau‐Remington, F. (2006) · The Journal of Infectious Diseases · doi:10.1086/503777 · Cited by 310
Oliveira, D. C., Tomasz, A., & de Lencastre, H. (2001) · Microbial Drug Resistance · doi:10.1089/10766290152773365 · Cited by 301
Milheiriço, C., Oliveira, D. C., & de Lencastre, H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm112 · Cited by 297
MgrA Is a Multiple Regulator of Two New Efflux Pumps in Staphylococcus aureus
Truong-Bolduc, Q. C., Dunman, P. M., Strahilevitz, J., Projan, S. J., & Hooper, D. C. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2395-2405.2005 · Cited by 296
Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus
Trzcinski, K., Cooper, B. S., Hryniewicz, W., & Dowson, C. G. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.6.763 · Cited by 275
Antonelli, A., D’Andrea, M. M., Brenciani, A., Galeotti, C. L., Morroni, G., Pollini, S., Varaldo, P. E., & Rossolini, G. M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky088 · Cited by 257
Gentamicin resistance genes in environmental bacteria: prevalence and transfer
Heuer, H., Krögerrecklenfort, E., Wellington, E. M. H., Egan, S. A., van Elsas, J. D., van Overbeek, L. S., Collard, J., Guillaume, G., Karagouni, A. D., Nikolakopoulou, T. L., et al. (2002) · FEMS Microbiology Ecology · doi:10.1016/s0168-6496(02)00342-2 · Cited by 255
Vancomycin-resistant Staphylococcus aureus--New York, 2004.
(2004) · PubMed · Cited by 252
Meka, V. G., Pillai, S. K., Sakoulas, G., Wennersten, C., Venkataraman, L., DeGirolami, P. C., Eliopoulos, G. M., Moellering, Jr., & Gold, H. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/421471 · Cited by 247
Weigel, L. M., Donlan, R. M., Shin, D. H., Jensen, B., Clark, N. C., McDougal, L. K., Zhu, W., Musser, K. A., Thompson, J., Kohlerschmidt, D., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-06 · Cited by 237
Mendes, R. E., Deshpande, L. M., Castanheira, M., DiPersio, J., Saubolle, M. A., & Jones, R. N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00231-08 · Cited by 226
Aubry-Damon, H., Soussy, C.-J., & Courvalin, P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2590 · Cited by 225
Tomasz, A., Drugeon, H. B., de Lencastre, H. M., Jabes, D., McDougall, L., & Bille, J. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.11.1869 · Cited by 223
Argudín, M. A., Tenhagen, B.-A., Fetsch, A., Sachsenröder, J., Käsbohrer, A., Schroeter, A., Hammerl, J. A., Hertwig, S., Helmuth, R., Bräunig, J., et al. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.02260-10 · Cited by 215
The MSCRAMM Family of Cell-Wall-Anchored Surface Proteins of Gram-Positive Cocci
Foster, T. J. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.06.007 · Cited by 214
Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance
Zeng, D., Debabov, D., Hartsell, T. L., Cano, R. J., Adams, S., Schuyler, J. A., McMillan, R., & Pace, J. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026989 · Cited by 211
Redefining a Structural Variant of Staphylococcal Cassette Chromosome mec , SCC mec Type VI
Oliveira, D. C., Milheiriço, C., & de Lencastre, H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00629-06 · Cited by 205
Li, S., Skov, R. L., Han, X., Larsen, A. R., Larsen, J., Sørum, M., Wulf, M. W. H., Voß, A., Hiramatsu, K., & Ito, T. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01475-10 · Cited by 202
Plasmid-Encoded Transferable mecB-Mediated Methicillin Resistance in Staphylococcus aureus
Becker, K., van Alen, S., Idelevich, E. A., Schleimer, N., Seggewiß, J., Mellmann, A., Kaspar, U., & Peters, G. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2402.171074 · Cited by 200
Zhang, K., McClure, J.-A., Elsayed, S., & Conly, J. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01118-08 · Cited by 196
Saha, B., Singh, A. K., Ghosh, A., & Bal, M. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47144-0 · Cited by 195
Schmitz, F.-J., Sadurski, R., Kray, A., Boos, M., Geisel, R., Kohrer, K., Verhoef, J., & Fluit, A. C. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.6.891 · Cited by 191
Surface Proteins ofStaphylococcus aureus
Foster, T. J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0046-2018 · Cited by 184
Steward, C. D., Raney, P. M., Morrell, A. K., Williams, P. P., McDougal, L. K., Jevitt, L., McGowan, J. E., & Tenover, F. C. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1716-1721.2005 · Cited by 180
Katayama, Y., Ito, T., & Hiramatsu, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.1955-1963.2001 · Cited by 179
Gómez-Sanz, E., Torres, C., Lozano, C., Fernández-Pérez, R., Aspíroz, C., Ruiz‐Larrea, F., & Zarazaga, M. (2010) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2010.0610 · Cited by 178
D'Souza, N., Rodrigues, C., & Mehta, A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01867-09 · Cited by 178
Schnellmann, C., Gerber, V., Rossano, A., Jaquier, V., Panchaud, Y., Doherr, M. G., Thomann, A., Straub, R., & Perreten, V. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00868-06 · Cited by 178
Neoh, H., Cui, L., Yuzawa, H., Takeuchi, F., Matsuo, M., & Hiramatsu, K. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00534-07 · Cited by 176
Origin, evolution, and global transmission of community-acquired Staphylococcus aureus ST8
Strauß, L., Stegger, M., Akpaka, P. E., Alabi, A. S., Breurec, S., Coombs, G. W., Egyir, B., Larsen, A. R., Laurent, F. J., Monecke, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702472114 · Cited by 172
Takano, T., Higuchi, W., Otsuka, T., Baranovich, T., Enany, S., Saito, K., Isobe, H., Dohmae, S., Ozaki, K., Takano, M., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01001-07 · Cited by 171
Shore, A., Rossney, A. S., Keane, C. T., Enright, M. C., & Coleman, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2070-2083.2005 · Cited by 170
Dissemination of Methicillin-Resistant Staphylococci among Healthy Japanese Children
Hisata, K., Kuwahara‐Arai, K., Yamanoto, M., Ito, T., Nakatomi, Y., Cui, L., Baba, T., Terasawa, M., Sotozono, C., Kinoshita, S., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3364-3372.2005 · Cited by 168
Miragaia, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02723 · Cited by 168
MupB, a New High-Level Mupirocin Resistance Mechanism in Staphylococcus aureus
Seah, C., Alexander, D. C., Louie, L., Simor, A. E., Low, D. E., Longtin, J., & Melano, R. G. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05325-11 · Cited by 166
Current Status of Staphylococcal Cassette Chromosome mec (SCCmec)
Uehara, Y. (2022) · Antibiotics · doi:10.3390/antibiotics11010086 · Cited by 166
Kwon, N. H., Park, K. T., Moon, J. S., Jung, W. K., Kim, S. H., Kim, J. M., Hong, S. K., Koo, H. C., Joo, Y. S., & Park, Y. H. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki306 · Cited by 165
Ding, Y., Onodera, Y., Lee, J. C., & Hooper, D. C. (2008) · Journal of Bacteriology · doi:10.1128/jb.00655-08 · Cited by 164
Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides
Wondrack, L. M., Massa, M. A., Yang, B. V., & Sutcliffe, J. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.992 · Cited by 162
Antimicrobial resistance in Europe and its potential impact on empirical therapy
Rossolini, G. M., & Mantengoli, E. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02126.x · Cited by 160
Small colony variants of Staphylococcus aureus — review
Melter, O., & Radojevič, B. (2010) · Folia Microbiologica · doi:10.1007/s12223-010-0089-3 · Cited by 160
Mongkolrattanothai, K., Boyle, S., Murphy, T. V., & Daum, R. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1823-1836.2004 · Cited by 145
Novel SCC mec type XIII (9A) identified in an ST152 methicillin-resistant Staphylococcus aureus
Baig, S., Johannesen, T. B., Overballe‐Petersen, S., Larsen, J., Larsen, A. R., & Stegger, M. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.03.013 · Cited by 145
McDougal, L. K., Fosheim, G. E., Nicholson, A., Bulens, S. N., Limbago, B. M., Shearer, J. E. S., Summers, A. O., & Patel, J. B. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00351-10 · Cited by 143
Quinupristin/dalfopristin: A therapeutic review
Allington, D. R., & Rivey, M. P. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80028-x · Cited by 140
Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics
Colca, J. R., McDonald, W. G., Waldon, D. J., Thomasco, L. M., Gadwood, R. C., Lund, E. T., Cavey, G. S., Mathews, W. R., Adams, L. D., Cecil, E. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302109200 · Cited by 139
Liu, W.-T., Chen, E.-Z., Yang, L., Peng, C., Wang, Q., Xu, Z., & Chen, D.-Q. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104915 · Cited by 138
Venugopal, A. A., & Johnson, S. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir830 · Cited by 135
Rouch, D. A., Messerotti, L. J., Loo, L. S. L., Jackson, C. A., & Skurray, R. A. (1989) · Molecular Microbiology · doi:10.1111/j.1365-2958.1989.tb01805.x · Cited by 131
Ohnishi, Y., Okino, N., Ito, M., & Imayama, S. (1999) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.6.1.101-104.1999 · Cited by 128
Yang, S., Kreiswirth, B. N., Sakoulas, G., Yeaman, M. R., Xiong, Y. Q., Sawa, A., & Bayer, A. S. (2009) · The Journal of Infectious Diseases · doi:10.1086/648473 · Cited by 126
Wu, Z., Fan, L., Liu, D., Xue, H., & Zhao, X. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01692-15 · Cited by 126
Xue, X., Ito, T., Chongtrakool, P., & Hiramatsu, K. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00985-06 · Cited by 125
Xu, Z., Li, L., Shirtliff, M. E., Peters, B. M., Li, B., Peng, Y., Alam, M. J., Yamasaki, S., & Shi, L. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03379.x · Cited by 119
Molecular basis of fusB‐mediated resistance to fusidic acid in Staphylococcus aureus
O’Neill, A. J., & Chopra, I. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04971.x · Cited by 118
Mehta, S., Cuirolo, A. X., Plata, K. B., Riosa, S., Silverman, J. A., Rubio, A., Rosato, R. R., & Rosato, A. E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00432-10 · Cited by 118
Zhu, W., Clark, N. C., McDougal, L. K., Hageman, J., McDonald, L. C., & Patel, J. B. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00908-07 · Cited by 117
IS 21-558 Insertion Sequences Are Involved in the Mobility of the Multiresistance Gene cfr
Kehrenberg, C., Aarestrup, F. M., & Schwarz, S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01340-06 · Cited by 115
Allignet, J., & Solh, N. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.2027 · Cited by 115
Banerjee, R., Gretes, M., Harlem, C., Basuino, L., & Chambers, H. F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00594-10 · Cited by 112
O’Neill, A. J., Larsen, A. R., Skov, R. L., Henriksen, A. S., & Chopra, I. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01984-06 · Cited by 111
Wang, B., Xu, Y., Zhao, H., Wang, X., Rao, L., Guo, Y., Yi, X., Hu, L., Chen, S., Han, L., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2032373 · Cited by 111
Zong, Z., Peng, C., & Lü, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020191 · Cited by 110
Kadlec, K., & Schwarz, Š. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00570-09 · Cited by 110
Allignet, J., Loncle, V., Simenel, C., Delepierre, M., & Solh, N. E. (1993) · Gene · doi:10.1016/0378-1119(93)90350-c · Cited by 110
Berglund, C., Ito, T., Ikeda, M., Xue, X., Söderquist, B., & Hiramatsu, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00087-08 · Cited by 110
Egyir, B., Guardabassi, L., Sørum, M., Nielsen, S. S., Kolekang, A., Frimpong, E., Addo, K. K., Newman, M. J., & Larsen, A. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089716 · Cited by 108
Kadlec, K., & Schwarz, Š. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01128-08 · Cited by 106
Projan, S. J., Kornblum, J. S., Moghazeh, S. L., Edelman, I., Gennaro, M. L., & Novick, R. P. (1985) · Molecular and General Genetics MGG · doi:10.1007/bf00330758 · Cited by 104
Ida, T., Okamoto, R., Shimauchi, C., Okubo, T., Kuga, A., & Inoue, M. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3115-3121.2001 · Cited by 103
Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States
Limbago, B. M., Kallen, A. J., Zhu, W., Eggers, P., McDougal, L. K., & Albrecht, V. S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02187-13 · Cited by 101
Jansen, A., Türck, M., Szekat, C., Nagel, M., Clever, I., & Bierbaum, G. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.02.002 · Cited by 100
Zhang, S., Sun, X., Chang, W., Dai, Y., & Ma, X. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136082 · Cited by 99
Projan, S. J., Monod, M., Narayanan, C. S., & Dubnau, D. A. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.11.5131-5139.1987 · Cited by 99
Regulation of mprF in Daptomycin-Nonsusceptible Staphylococcus aureus Strains
Yang, S.-J., Xiong, Y. Q., Dunman, P. M., Schrenzel, J., François, P., Peschel, A., & Bayer, A. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01415-08 · Cited by 98
de Vries, L. E., Christensen, H. K., Skov, R. L., Aarestrup, F. M., & Agersø, Y. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp214 · Cited by 97
Schwendener, S., & Perreten, V. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00528-11 · Cited by 94
O’Brien, F. G., Price, C. T. D., Grubb, W. B., & Gustafson, J. E. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf153 · Cited by 91
Shore, A. C., Brennan, O. M., Ehricht, R., Monecke, S., Schwarz, S., Slickers, P., & Coleman, D. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01113-10 · Cited by 90
Kadlec, K., & Schwarz, Š. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01091-09 · Cited by 89
Urushibara, N., Aung, M. S., Kawaguchiya, M., & Kobayashi, N. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz406 · Cited by 89
First confirmation of integron-bearing methicillin-resistant Staphylococcus aureus
Xu, Z., Li, L., Alam, M. J., Zhang, L., Yamasaki, S., & Shi, L. (2008) · Current Microbiology · doi:10.1007/s00284-008-9187-8 · Cited by 88
Argudín, M. A., Roisin, S., Nienhaus, L., Dodémont, M., de Mendonça, R., Nonhoff, C., Deplano, A., & Denis, O. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00091-18 · Cited by 88
Weisblum, B. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80212-4 · Cited by 87
Derbise, A., Dyke, K. G. H., & Solh, N. E. (1996) · Plasmid · doi:10.1006/plas.1996.0020 · Cited by 86
Xiao, M., Wang, H., Zhao, Y. Y., Mao, L.-L., Brown, M., Yu, Y., O'Sullivan, M. V. N., Kong, F., & Xu, Y. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01375-13 · Cited by 84
Investigation of aminoglycoside modifying enzyme genes in methicillin-resistant staphylococci
Ardic, N., Sareyyupoglu, B., Ozyurt, M., Haznedaroglu, T., & Ilga, U. (2006) · Microbiological Research · doi:10.1016/j.micres.2005.05.002 · Cited by 80
Brenner, D. G., & Shaw, W. V. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03665.x · Cited by 79
Allignet, J., Liassine, N., & Solh, N. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1794 · Cited by 79
Lüthje, P., & Schwarz, Š. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.12.016 · Cited by 79
Staphylococcal cassette chromosome mec (SCCmec) classification and typing methods: An overview
TURLEJ, A., HRYNIEWICZ, W., & EMPEL, J. (2011) · Polish Journal of Microbiology · doi:10.33073/pjm-2011-013 · Cited by 74
Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance
Clark, J. A., & Burgess, D. S. (2020) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936120952604 · Cited by 74
Staphylococcus aureus heme and siderophore-iron acquisition pathways
Conroy, B. S., Grigg, J. C., Kolesnikov, M., Morales, L. D., & Murphy, M. E. P. (2019) · BioMetals · doi:10.1007/s10534-019-00188-2 · Cited by 73
Malbruny, B., Canu, A., Bozdogan, B., Fantin, B., Zarrouk, V., Dutka-Malen, S., Feger, C., & Leclercq, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2200-2207.2002 · Cited by 70
Mukhtar, T. A., Koteva, K. K., Hughes, D. W., & Wright, G. D. (2001) · Biochemistry · doi:10.1021/bi0106787 · Cited by 70
Lozano, C., Rezusta, A., Gomez, P., Gomez-Sanz, E., Baez, N., Martin-Saco, G., Zarazaga, M., & Torres, C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr497 · Cited by 69
Risk factors associated with mupirocin resistance in meticillin-resistant Staphylococcus aureus
Caffrey, A. R., Quilliam, B. J., & LaPlante, K. L. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.06.023 · Cited by 67
Greninger, A. L., Chatterjee, S. S., Chan, L. C., Hamilton, S. M., Chambers, H. F., & Chiu, C. Y. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149541 · Cited by 66
Kim, J., Song, W., Kim, H.-S., Cho, H. C., Lee, K. M., Choi, M., & Kim, E. C. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.05.003 · Cited by 65
Chlebowicz, M. A., Nganou, K., Kozytska, S., Arends, J. P., Engelmann, S., Grundmann, H., Ohlsen, K., van Dijl, J. M., & Buist, G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00696-09 · Cited by 65
Senok, A. C., Ehricht, R., Monecke, S., AlSaedan, R. A., & Somily, A. M. (2016) · New Microbes and New Infections · doi:10.1016/j.nmni.2016.07.009 · Cited by 65
Quorum Sensing and Toxin Production in Staphylococcus aureus Osteomyelitis: Pathogenesis and Paradox
Butrico, C. E., & Cassat, J. E. (2020) · Toxins · doi:10.3390/toxins12080516 · Cited by 65
Novais, C., Freitas, A. R., Sousa, J. C., Baquero, F., Coque, T. M., & Peixe, L. V. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00999-07 · Cited by 64
Katayama, Y., Sekine, M., Hishinuma, T., Aiba, Y., & Hiramatsu, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00420-16 · Cited by 63
Characterization of the Modular Design of the Autolysin/Adhesin Aaa from Staphylococcus Aureus
Nina, H., Schlesier, T., Peters, G., & Heilmann, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040353 · Cited by 60
Autolysin mediated adherence of Staphylococcus aureus with Fibronectin, Gelatin and Heparin
Chandni, P., Suresh, M. K., Biswas, R., Nair, B. G., Mishra, N., & Pal, S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.01.047 · Cited by 59
Haroche, J., Allignet, J., Buchrieser, C., & Solh, N. E. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2271-2275.2000 · Cited by 58
Langley, R. J., Ting, Y. T., Clow, F., Young, P. G., Radcliff, F. J., Choi, J. M., Sequeira, R. P., Holtfreter, S., Baker, H. M., & Fraser, J. D. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006549 · Cited by 58
Hill, R. L. R., Kearns, A. M., Nash, J., North, S. E., Pike, R., Newson, T., Woodford, N., Calver, R., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp494 · Cited by 57
Distribution of mef (A) in Gram-Positive Bacteria from Healthy Portuguese Children
Luna, V. A., Heiken, M., Judge, K., Ulep, C. C., van Kirk, N., Luís, H., Bernardo, M. F., Leitao, J., & Roberts, M. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2513-2517.2002 · Cited by 56
Oliveira, D. C., & de Lencastre, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023287 · Cited by 55
Cloning of the gene conferring resistance to mupirocin in Staphylococcus aureus
Dyke, K. G. H., Curnock, S. P., Golding, M., & Noble, W. C. (1991) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1991.tb04346.x · Cited by 55
An Accessory Protein Is Required for Relaxosome Formation by Small Staphylococcal Plasmids
Smith, M. C. A., & Thomas, C. D. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.11.3363-3373.2004 · Cited by 55
Yu, F., Cienfuegos-Gallet, A. V., Cunningham, M. H., Jin, Y., Wang, B., Kreiswirth, B. N., & Chen, L. (2021) · mSystems · doi:10.1128/msystems.00492-21 · Cited by 55
Lannergård, J., Norström, T., & Hughes, D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00871-08 · Cited by 54
Haroche, J., Allignet, J., & Solh, N. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2337-2343.2002 · Cited by 54
Mechanisms of Methicillin Resistance in Staphylcoccus aureus and Methods for Laboratory Detection
Jorgensen, J. H. (1991) · Infection Control and Hospital Epidemiology · doi:10.2307/30147084 · Cited by 53
Berglund, C., Ito, T., X., X., Ikeda, M., Watanabe, S., Söderquist, B., & Hiramatsu, K. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn435 · Cited by 53
Guay, G. G., Khan, S. A., & Rothstein, D. M. (1993) · Plasmid · doi:10.1006/plas.1993.1045 · Cited by 52
Cadilla, A., David, M. Z., Daum, R. S., & Boyle-Vavra, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00759-10 · Cited by 52
Schmitz, F., Petridou, J., Fluit, A. C., Hadding, U., Peters, G., & von Eiff, C. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050500 · Cited by 50
Emaneini, M., Taherikalani, M., Eslampour, M. A., Sedaghat, H., Aligholi, M., Jabalameli, F., Shahsavan, S., & Sotoudeh, N. (2009) · Microbial Drug Resistance · doi:10.1089/mdr.2009.0869 · Cited by 49
The Staphylococcal Insertion Sequence IS257Is Active
Needham, C., Noble, W. C., & Dyke, K. G. H. (1995) · Plasmid · doi:10.1006/plas.1995.0005 · Cited by 48
Catchpole, I. R., Thomas, C. D., DAVIES, A., & Dyke, K. G. H. (1988) · Microbiology · doi:10.1099/00221287-134-3-697 · Cited by 48
Müller, A., Grein, F., Otto, A., Gries, K., Orlov, D., Zarubaev, V., Girard, M., Sher, X., Shamova, O., Roemer, T., et al. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.12.002 · Cited by 48
Haroche, J., Morvan, A., Davi, M., Allignet, J., Bimet, F., & Solh, N. E. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.2.586-591.2003 · Cited by 44
Périchon, B., & Courvalin, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4281-4285.2004 · Cited by 44
Hryniewicz, W. (1999) · Infection · doi:10.1007/bf02561663 · Cited by 43
Aminoglycoside-resistance mechanisms in multidrug-resistant Staphylococcus aureus clinical isolates
Kelmani Chandrakanth, R., Raju, S., & Patil, S. A. (2008) · Current Microbiology · doi:10.1007/s00284-008-9123-y · Cited by 42
Pérez-Roth, E., Kwong, S. M., Alcoba-Florez, J., Firth, N., & Méndez-Álvarez, S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01074-09 · Cited by 42
LACEY, R. W., & Rosdahl, V. T. (1974) · Journal of Medical Microbiology · doi:10.1099/00222615-7-1-1 · Cited by 41
Schwarz, Š., & Cardoso, M. R. D. I. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1551 · Cited by 41
Baig, S., Larsen, A. R., Martins-Simões, P., Laurent, F. J., Johannesen, T. B., Lilje, B., Tristan, A., Schaumburg, F., Egyir, B., Cirkovic, I. B., et al. (2020) · mSphere · doi:10.1128/msphere.00226-20 · Cited by 41
Characterization of a New SCCmec Element in Staphylococcus cohnii
Zong, Z., & Lu, X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014016 · Cited by 40
Schwarz, S., Spies, U., & Cardoso, M. R. D. I. (1991) · Journal of General Microbiology · doi:10.1099/00221287-137-4-977 · Cited by 40
New and emerging treatment of Staphylococcus aureus infections in the hospital setting
Moreillon, P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01961.x · Cited by 39
Mechanisms of Methicillin Resistance in Staphylcoccus aureus and Methods for Laboratory Detection
Jorgensen, J. H. (1991) · Infection Control & Hospital Epidemiology · doi:10.1086/646233 · Cited by 39
Unnoticed spread of class 1 integrons in gram-positive clinical strains isolated in Guangzhou, China
Shi, L., Zheng, M., Xiao, Z., Asakura, M., Su, J., Li, L., & Yamasaki, S. (2006) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2006.tb03815.x · Cited by 38
Courjon, J., Munro, P. M., Benito, Y., Visvikis, O., Bouchiat, C., Boyer, L., Doye, A., Lépidi, H., Ghigo, É., Lavigne, J., et al. (2015) · Toxins · doi:10.3390/toxins7104131 · Cited by 38
DNA Microarray for Detection of Macrolide Resistance Genes
Cassone, M., D’Andrea, M. M., Iannelli, F., Oggioni, M. R., Rossolini, G. M., & Pozzi, G. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01574-05 · Cited by 38
Yadegar, A., Sattari, M., Mozafari, N. A., & Goudarzi, G. R. (2009) · Microbial Drug Resistance · doi:10.1089/mdr.2009.0897 · Cited by 37
Chen, L., Mediavilla, J. R., Smyth, D. S., Chavda, K. D., Ionescu, R., Roberts, R. B., Robinson, D. A., & Kreiswirth, B. N. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00001-10 · Cited by 37
Staphylococcus aureus Strain-Dependent Biofilm Formation in Bone-Like Environment
Lamret, F., Varin-Simon, J., Velard, F., Terryn, C., Mongaret, C., Colin, M., Gangloff, S. C., & Reffuveille, F. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.714994 · Cited by 37
Derbise, A., de Cespédès, G., & Solh, N. E. (1997) · Journal of Basic Microbiology · doi:10.1002/jobm.3620370511 · Cited by 36
Bakthavatchalam, Y. D., Babu, P., Munusamy, E., Dwarakanathan, H. T., Rupali, P., Zervos, M., John Victor, P., & Veeraraghavan, B. (2019) · PLOS ONE · doi:10.1371/journal.pone.0227009 · Cited by 36
Earls, M. R., Coleman, D. C., Brennan, G. I., Fleming, T. E., Monecke, S., Slickers, P., Ehricht, R., & Shore, A. C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01485 · Cited by 35
Hurdle, J. G. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh020 · Cited by 34
Burdeska, A., Ott, M., Bannwarth, W., & Then, R. L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81529-w · Cited by 34
Loeza-Lara, P. D., Soto-Huipe, M., Baizabal-Aguirre, V. M., Ochoa‐Zarzosa, A., Valdez-Alarcón, J. J., Cano-Camacho, H., & López-Meza, J. E. (2004) · Plasmid · doi:10.1016/j.plasmid.2004.03.001 · Cited by 34
van Hal, S. J., Steinig, E. J., Andersson, P., Holden, M. T. G., Harris, S. R., Nimmo, G. R., Williamson, D. A., Heffernan, H., Ritchie, S. R., Kearns, A. M., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01453 · Cited by 34
Kikuta, H., Shibata, M., Nakata, S., Yamanaka, T., Sakata, H., Akizawa, K., & Kobayashi, K. (2011) · International Journal of Pediatrics · doi:10.1155/2011/143872 · Cited by 33
Iwao, Y., Takano, T., Higuchi, W., & Yamamoto, T. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-011-0348-5 · Cited by 33
Zou, G., Matuszewska, M., Jia, M., Zhou, J., Ba, X., Duan, J., Zhang, C., Zhao, J. J., Tao, M., Fan, J., et al. (2021) · Advanced Science · doi:10.1002/advs.202103388 · Cited by 33
Cheng, J., Thanassi, J. A., Thoma, C. L., Bradbury, B. J., Deshpande, M., & Pucci, M. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00158-07 · Cited by 32
Lee, H., Yoon, E.-J., Kim, D., Kim, J. W., Lee, K.-J., Kim, H. S., Kim, Y. R., Shin, J. H., Shin, J. H., Shin, K. S., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00485-18 · Cited by 32
Evolutionary and Functional Analysis of Coagulase Positivity among the Staphylococci
Pickering, A. C., Yebra, G., Gong, X., Goncheva, M. I., Wee, B. A., MacFadyen, A. C., Mühlbauer, L. F., Alves, J., Cartwright, R. A., Paterson, G. K., et al. (2021) · mSphere · doi:10.1128/msphere.00381-21 · Cited by 32
Noguchi, N., Aoki, T., Sasatsu, M., Kono, M., Shishido, K., & Ando, T. (1986) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1986.tb01809.x · Cited by 31
Sekiguchi, J., Fujino, T., Araake, M., Toyota, E., Kudo, K., Saruta, K., Kirikae, T., Yoshikura, H., & Kuratsuji, T. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-005-0417-8 · Cited by 31
The genome of Staphylococcus aureus: A review
Mŀynarczyk, A., Mŀynarczyk, G., & Jeljaszewicz, J. (1998) · Zentralblatt für Bakteriologie · doi:10.1016/s0934-8840(98)80165-5 · Cited by 31
Jin, Y., Zhou, W., Yin, Z., Zhang, S., Chen, Y., Shen, P., Ji, J., Chen, W., Zheng, B., & Xiao, Y. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1914516 · Cited by 31
Hisata, K., Ito, T., Jin, J., Li, S., Watanabe, S., Hiramatsu, K., Hisata, K., Matsunaga, N., Komatsu, M., Shimizu, T., et al. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-011-0223-4 · Cited by 30
Pankuch, G. A., Jacobs, M. R., & Appelbaum, P. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.3028 · Cited by 30
New erm Gene in Staphylococcus aureus Clinical Isolates
Matsuoka, M., Inoue, M., Nakajima, Y., & Endo, Y. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.211-215.2002 · Cited by 30
Morroni, G., Brenciani, A., Brescini, L., Fioriti, S., Simoni, S., Pocognoli, A., Mingoia, M., Giovanetti, E., Barchiesi, F., Giacometti, A., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01663-18 · Cited by 30
An Outbreak of Borderline Oxacillin-Resistant Staphylococcus aureus (BORSA) in a Dermatological Unit
Balslev, U., Bremmelgaard, A., Svejgaard, E., Havstreym, J., & Westh, H. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.78 · Cited by 29
Urushibara, N., Paul, S. K., Hossain, M. A., Kawaguchiya, M., & Kobayashi, N. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2010.0144 · Cited by 29
Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria
Amdahl, H., Haapasalo, K., Tan, L., Meri, T., Kuusela, P., van Strijp, J. A. G., Rooijakkers, S. H. M., & Jokiranta, T. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172675 · Cited by 29
Zhao, X., Chlebowicz-Fliss, M. A., Wang, M., Murguia, E. V., de Jong, A., Becher, D., Maaß, S., Buist, G., & van Dijl, J. M. (2020) · Virulence · doi:10.1080/21505594.2020.1793525 · Cited by 29
Frontiers in Antimicrobial Resistance: a Tribute to Stuart B. Levy
(2005) · doi:10.1128/9781555817572 · Cited by 28
Boswihi, S. S., Udo, E. E., & Alfouzan, W. A. (2020) · BMC Microbiology · doi:10.1186/s12866-020-02009-w · Cited by 28
Prunier, A.-L., Trong, H. N., Tande, D., Segond, C., & Leclercq, R. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.18 · Cited by 26
Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A)
Malhotra-Kumar, S., Mazzariol, A., Van Heirstraeten, L., Lammens, C., de Rijk, P., Cornaglia, G., & Goossens, H. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn432 · Cited by 26
Ogura, K., Kaji, D., Sasaki, M., Otsuka, Y., Takemoto, N., Miyoshi‐Akiyama, T., & Kikuchi, K. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.01.011 · Cited by 26
Worthing, K. A., Schwendener, S., Perreten, V., Saputra, S., Coombs, G. W., Pang, S., Davies, M. R., Abraham, S., Trott, D. J., & Norris, J. M. (2018) · mSphere · doi:10.1128/msphere.00491-18 · Cited by 25
Research works printed but not linked: 1
- (2022, February 03). Taxonomy Browser (Staphylococcus), Available online: https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi.
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Mechanism of staphylococcal resistance to clinically relevant antibiotics
Brdová, D., Ruml, T., & Viktorová, J. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101147 · Cited by 135
Bashabsheh, R. H. F., Al-Fawares, O., Natsheh, I. Y., Bdeir, R., Al-Khreshieh, R. O., & Bashabsheh, H. H. F. (2023) · Pathogens and Global Health · doi:10.1080/20477724.2023.2285187 · Cited by 112
Evaluation of Antibiotic Resistance Mechanisms in Gram-Positive Bacteria
Rajput, P., Nahar, K. S., & Rahman, K. M. (2024) · Antibiotics · doi:10.3390/antibiotics13121197 · Cited by 114
Qiu, M., Zheng, M., Zhang, J., Yang, X., Zhang, Y., Zhang, W., Man, C., Zhao, Q., & Jiang, Y. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117258 · Cited by 78
Metadata
- Authors
- Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W.
- Affiliations
- Department of Dermatology, Immunodermatology and Venereology, Medical University of Warsaw, Koszykowa 82a, 02-008 Warsaw, Poland
- Academy of Face Sculpting, Jana Kazimierza 11B, 01-248 Warsaw, Poland
- Corresponding author
- Marusza, Wojciech
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-07-22
- Volume
- 23
- Issue
- 15
- Pages
- 8088
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9332259
- OpenAlex
- W4286587477
- Cited by
- 412
- References
- 242
- Citations by year
- 2026: 103 · 2025: 122 · 2024: 114 · 2023: 59 · 2022: 13
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Staphylococcus aureus, antibiotic resistance, methicillin-resistant Staphylococcus aureus, beta-lactam resistance, mec gene, glycopeptide resistance, vancomycin resistance, oxazolidinone resistance, linezolid, aminoglycoside resistance, fluoroquinolone resistance, tetracycline resistance, mupirocin resistance, fusidic acid resistance, daptomycin resistance, molecular epidemiology, virulence genes
- MeSH terms
- Aminoglycosides, Anti-Bacterial Agents, Drug Resistance, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.